Discover how El Camino Health's multidisciplinary approach enhances cancer care for younger adults, featuring collaboration among diverse medical specialists. In an interview with Targeted Oncology, ...

The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for certain adults ...

The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals and Roche's combination therapy as a maintenance ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

UD News The National Institutes of Health has awarded nearly a half-million dollars to two University of Dayton researchers ...

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be ...

An innovative approach could transform the treatment landscape for DLBCL patients, offering hope to those who might otherwise ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.

A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types ...

MONDAY, Sept. 22, 2025 (HealthDay News) — A Los Angeles-area dad is surviving leukemia thanks to his 10-year-old son, who ...

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and ...

Right now, breast cancer that comes back is virtually impossible to eliminate completely, which leads to a large proportion ...